Brief: Biosynex To Buy Enalees' Human Health Business

Biosynex SA

23/11/2021 07:07

Nov 23 (Reuters) - Biosynex SA  ALBIO.PA :
    * ANNOUNCES IT HAS SIGNED A BINDING LETTER OF OFFER TO
ACQUIRE THE
HUMAN HEALTH BUSINESS OF ENALEES
    * THIS ACQUISITION WOULD INCLUDE A RAPID MOLECULAR
DIAGNOSTIC TEST
SOLUTION BASED ON A MOLECULAR DIAGNOSTIC TEST SOLUTION BASED ON
AN ISOTHERMAL AMPLIFICATION METHOD
    * ENALEES HAS GRANTED BIOSYNEX AN EXCLUSIVITY PERIOD UNTIL
JANUARY
31, 2022
    * LTHE FINAL COMPLETION OF THIS OPERATION IS EXPECTED BY THE
END
OF DECEMBER 2021

Source text for Eikon:  ID:nEQbxXM4ya 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))